Piperazine-substituted [1,2,4]triazolo[1,5-C]quinazolin-5-amine compounds with A2A antagonist properties
US-9676780-B2 · Jun 13, 2017 · US
This page is not indexed by search engines while we improve data quality.
Zorn Nicolas patents
Zorn Nicolas holds 4 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 4 |
| Recent patents | 0 |
| First publication | Jan 26, 2016 |
| Latest publication | Jun 13, 2017 |
Filing trend
Year-over-year patent counts for this assignee.
Recent patents
Latest publications where this party is an assignee.
Heterocyclic compounds and methods of use thereof for the treatment of hepatitis C
US-9549921-B2 · Jan 24, 2017 · US
Heterocyclic compounds and methods of use thereof for the treatment of hepatitis c
US-2016143895-A1 · May 26, 2016 · US
Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis C
US-9242998-B2 · Jan 26, 2016 · US
Notable patents
Representative or frequently cited publications from precomputed assignee stats.
Piperazine-substituted [1,2,4]triazolo[1,5-C]quinazolin-5-amine compounds with A2A antagonist properties
US-9676780-B2 · Jun 13, 2017 · US
Heterocyclic compounds and methods of use thereof for the treatment of hepatitis C
US-9549921-B2 · Jan 24, 2017 · US
Heterocyclic compounds and methods of use thereof for the treatment of hepatitis c
US-2016143895-A1 · May 26, 2016 · US
Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis C
US-9242998-B2 · Jan 26, 2016 · US
Technology areas
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Human Necessities | 4 |
| Chemistry & Metallurgy | 4 |